RMTI
Income statement / Annual
Last year (2023), Rockwell Medical, Inc.'s total revenue was $83.61 M,
an increase of 14.84% from the previous year.
In 2023, Rockwell Medical, Inc.'s net income was -$8.44 M.
See Rockwell Medical, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$83.61 M
|
$72.81 M
|
$61.93 M
|
$62.20 M
|
$61.30 M
|
$63.39 M
|
$57.30 M
|
$53.28 M
|
$55.35 M
|
$54.19 M
|
| Cost of Revenue |
$74.91 M |
$68.73 M |
$64.35 M |
$59.47 M |
$58.46 M |
$64.97 M |
$53.60 M |
$46.53 M |
$46.41 M |
$45.64 M |
| Gross Profit |
$8.70 M |
$4.08 M |
-$2.42 M |
$2.73 M |
$2.84 M |
-$1.58 M |
$3.70 M |
$6.75 M |
$8.94 M |
$8.55 M |
| Gross Profit Ratio |
0.1 |
0.06 |
-0.04 |
0.04 |
0.05 |
-0.02 |
0.06 |
0.13 |
0.16 |
0.16 |
| Research and Development
Expenses |
$1.11 M
|
$3.12 M
|
$6.84 M
|
$7.09 M
|
$6.89 M
|
$6.74 M
|
$6.32 M
|
$5.84 M
|
$4.96 M
|
$7.78 M
|
| General & Administrative
Expenses |
$12.14 M
|
$15.64 M
|
$15.35 M
|
$16.18 M
|
$21.00 M
|
$23.08 M
|
$23.30 M
|
$21.12 M
|
$19.08 M
|
$18.32 M
|
| Selling & Marketing
Expenses |
$2.13 M
|
$2.09 M
|
$5.73 M
|
$7.87 M
|
$9.05 M
|
$1.00 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$14.27 M
|
$17.74 M
|
$21.08 M
|
$24.05 M
|
$30.05 M
|
$23.08 M
|
$23.30 M
|
$21.12 M
|
$19.08 M
|
$18.32 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
-$837,000.00 |
-$430,000.00 |
-$1.03 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$15.37 M |
$20.86 M |
$27.92 M |
$31.15 M |
$36.93 M |
$29.82 M |
$29.62 M |
$26.96 M |
$24.04 M |
$26.10 M |
| Cost And Expenses |
$90.28 M |
$89.59 M |
$92.27 M |
$90.62 M |
$95.40 M |
$94.80 M |
$83.22 M |
$73.49 M |
$70.45 M |
$71.75 M |
| Interest Income |
$211,000.00 |
$33,000.00 |
$22,000.00 |
$238,000.00 |
$367,077.00 |
$535,328.00 |
$892.00 |
$810,340.00 |
$681,876.00 |
$386,257.00 |
| Interest Expense |
$2.30 M |
$1.94 M |
$2.36 M |
$1.88 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$4.15 M |
| Depreciation &
Amortization |
$1.44 M
|
$2.59 M
|
$2.52 M
|
$2.29 M
|
$2.65 M
|
$650,142.00
|
$514,362.00
|
$762,368.00
|
$822,294.00
|
$996,321.00
|
| EBITDA |
-$4.69 M
|
-$16.17 M
|
-$27.80 M
|
-$26.72 M
|
-$31.48 M
|
-$31.48 M
|
-$25.41 M
|
-$18.64 M
|
-$13.60 M
|
-$16.18 M
|
| EBITDA Ratio |
-0.06 |
-0.23 |
-0.45 |
-0.43 |
-0.56 |
-0.49 |
-0.44 |
-0.35 |
-0.26 |
-0.3 |
| Operating Income Ratio
|
-0.08
|
-0.23
|
-0.49
|
-0.46
|
-0.56
|
-0.51
|
-0.45
|
-0.38
|
-0.27
|
-0.32
|
| Total Other
Income/Expenses Net |
-$1.77 M
|
-$1.90 M
|
-$2.34 M
|
-$2.47 M
|
-$32,710.00
|
-$716,697.00
|
$1,634.00
|
$810,340.00
|
$681,876.00
|
-$3.77 M
|
| Income Before Tax |
-$8.44 M |
-$18.68 M |
-$32.67 M |
-$30.89 M |
-$34.13 M |
-$32.13 M |
-$25.92 M |
-$19.40 M |
-$14.42 M |
-$21.33 M |
| Income Before Tax Ratio
|
-0.1
|
-0.26
|
-0.53
|
-0.5
|
-0.56
|
-0.51
|
-0.45
|
-0.36
|
-0.26
|
-0.39
|
| Income Tax Expense |
$0.00 |
$1.90 M |
$2.36 M |
$1.04 M |
-$3.05 M |
$313,303.00 |
-$1,634.00 |
$404,527.00 |
$0.00 |
$386,257.00 |
| Net Income |
-$8.44 M |
-$20.58 M |
-$35.03 M |
-$31.93 M |
-$31.08 M |
-$32.13 M |
-$25.92 M |
-$19.80 M |
-$14.42 M |
-$21.33 M |
| Net Income Ratio |
-0.1 |
-0.28 |
-0.57 |
-0.51 |
-0.51 |
-0.51 |
-0.45 |
-0.37 |
-0.26 |
-0.39 |
| EPS |
-0.36 |
-2.09 |
-4.11 |
-4.64 |
-5.61 |
-6.69 |
-5.61 |
-4.3 |
-3.19 |
-5.72 |
| EPS Diluted |
-0.36 |
-2.09 |
-4.11 |
-4.64 |
-5.61 |
-6.69 |
-5.61 |
-4.29 |
-3.19 |
-5.67 |
| Weighted Average Shares
Out |
$23.32 M
|
$9.87 M
|
$8.53 M
|
$6.87 M
|
$5.54 M
|
$4.80 M
|
$4.62 M
|
$4.61 M
|
$4.52 M
|
$3.73 M
|
| Weighted Average Shares
Out Diluted |
$23.32 M
|
$9.87 M
|
$8.53 M
|
$6.87 M
|
$5.54 M
|
$4.80 M
|
$4.62 M
|
$4.62 M
|
$4.52 M
|
$3.76 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
